Philadelphia, PA, August 4, 2016 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that 10 Reaxys PhD Prize candidates have been short-listed from the 45 chemists nominated in May. The candidates will present at the annual Reaxys Prize Symposium to be held in conjunction with the New Scientist Live festival in London from September 22-23.
The oral presentation in September will be the last step in the reviewing process of the Reaxys PhD Prize, an international award that recognizes and rewards the most innovative research produced by chemistry's rising stars. The jury, which consists of members of the Reaxys Advisory Board, will chose three winners, who will be announced at the Symposium dinner on September 23.
The 10 shortlisted candidates are:
- Nickolas Anderson from the Bart group, Purdue University - West Lafayette
- Chuyang Cheng from the Stoddart group, Northwestern University
- Lauren Doyle from the Piers group, University of Calgary
- Pascal Ellerbrock from the Trauner group, Ludwig-Maximilian University of Munich
- Sebastian Grundner from the Lercher group, Technical University of Munich
- Jamie Hicks from the Jones group, Monash University
- Jiheong Kang from the Aida group, University of Tokyo
- Jarad Mason from the Long group, University of California Berkeley
- Yusuke Masuda from the Murakami group, Kyoto University
- Alison Wendlandt from the Stahl group, University of Wisconsin - Madison
All of the original 45 finalists from this year's prize have been invited to attend the Symposium and present their work during a poster session. The jury's review criteria include the originality, innovation, applicability, importance, and rigor of the reported research.
Since its introduction in 2010, the Reaxys PhD Prize has received more than 3,000 submissions, from nearly 650 universities worldwide. The Prize aims to not only nurture advances in chemistry by giving talented young chemists who have produced groundbreaking research the recognition they deserve, but also present them with opportunities to extend their network, unlock new sources of inspiration and share knowledge.
Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. http://www.
Reaxys is a trademark of RELX Intellectual Properties SA, used under license.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.